<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p16" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_16{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_16{left:341px;bottom:30px;}
#t3_16{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_16{left:377px;bottom:30px;}
#t5_16{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_16{left:540px;bottom:30px;}
#t7_16{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_16{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_16{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_16{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_16{left:285px;bottom:827px;letter-spacing:-0.25px;}
#tc_16{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_16{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_16{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_16{left:1108px;bottom:28px;letter-spacing:0.29px;}
#tg_16{left:37px;bottom:193px;}
#th_16{left:46px;bottom:188px;letter-spacing:-0.12px;}
#ti_16{left:240px;bottom:188px;}
#tj_16{left:37px;bottom:179px;}
#tk_16{left:43px;bottom:174px;letter-spacing:-0.11px;word-spacing:0.01px;}
#tl_16{left:46px;bottom:162px;letter-spacing:-0.11px;}
#tm_16{left:37px;bottom:153px;}
#tn_16{left:50px;bottom:148px;letter-spacing:-0.11px;}
#to_16{left:46px;bottom:136px;letter-spacing:-0.12px;word-spacing:-0.02px;}
#tp_16{left:46px;bottom:123px;letter-spacing:-0.11px;}
#tq_16{left:46px;bottom:111px;letter-spacing:-0.13px;word-spacing:0.02px;}
#tr_16{left:36px;bottom:778px;letter-spacing:-0.15px;word-spacing:0.06px;}
#ts_16{left:36px;bottom:748px;letter-spacing:0.48px;}
#tt_16{left:36px;bottom:729px;letter-spacing:0.25px;}
#tu_16{left:182px;bottom:748px;letter-spacing:0.32px;word-spacing:-0.31px;}
#tv_16{left:650px;bottom:748px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tw_16{left:1080px;bottom:641px;letter-spacing:-0.09px;}
#tx_16{left:1080px;bottom:623px;letter-spacing:-0.06px;}
#ty_16{left:1080px;bottom:604px;letter-spacing:-0.08px;}
#tz_16{left:1080px;bottom:586px;letter-spacing:-0.09px;}
#t10_16{left:1080px;bottom:568px;letter-spacing:-0.25px;}
#t11_16{left:944px;bottom:623px;letter-spacing:-0.1px;}
#t12_16{left:944px;bottom:604px;letter-spacing:-0.09px;}
#t13_16{left:944px;bottom:586px;letter-spacing:-0.08px;}
#t14_16{left:36px;bottom:465px;letter-spacing:-0.1px;}
#t15_16{left:36px;bottom:446px;letter-spacing:-0.11px;}
#t16_16{left:182px;bottom:323px;letter-spacing:-0.1px;}
#t17_16{left:182px;bottom:670px;letter-spacing:-0.09px;}
#t18_16{left:182px;bottom:652px;letter-spacing:-0.09px;}
#t19_16{left:182px;bottom:634px;letter-spacing:-0.08px;}
#t1a_16{left:182px;bottom:615px;letter-spacing:-0.08px;word-spacing:-0.34px;}
#t1b_16{left:182px;bottom:597px;letter-spacing:-0.1px;}
#t1c_16{left:265px;bottom:605px;letter-spacing:-0.11px;}
#t1d_16{left:182px;bottom:295px;letter-spacing:-0.1px;}
#t1e_16{left:182px;bottom:277px;letter-spacing:-0.1px;word-spacing:-0.2px;}
#t1f_16{left:441px;bottom:285px;letter-spacing:-0.12px;}
#t1g_16{left:182px;bottom:259px;letter-spacing:-0.09px;}
#t1h_16{left:182px;bottom:454px;letter-spacing:-0.1px;}
#t1i_16{left:182px;bottom:231px;letter-spacing:-0.1px;}
#t1j_16{left:179px;bottom:203px;letter-spacing:-0.08px;}
#t1k_16{left:353px;bottom:715px;letter-spacing:-0.1px;}
#t1l_16{left:353px;bottom:697px;letter-spacing:-0.09px;}
#t1m_16{left:508px;bottom:704px;}
#t1n_16{left:353px;bottom:505px;letter-spacing:-0.1px;}
#t1o_16{left:353px;bottom:487px;letter-spacing:-0.09px;}
#t1p_16{left:353px;bottom:468px;letter-spacing:-0.09px;}
#t1q_16{left:419px;bottom:476px;}
#t1r_16{left:483px;bottom:594px;letter-spacing:-0.09px;}
#t1s_16{left:483px;bottom:575px;letter-spacing:-0.09px;}
#t1t_16{left:483px;bottom:557px;letter-spacing:-0.1px;}
#t1u_16{left:480px;bottom:496px;letter-spacing:-0.1px;}
#t1v_16{left:482px;bottom:420px;letter-spacing:-0.08px;}
#t1w_16{left:482px;bottom:402px;letter-spacing:-0.09px;}
#t1x_16{left:645px;bottom:574px;letter-spacing:-0.1px;}
#t1y_16{left:812px;bottom:581px;letter-spacing:-0.12px;}
#t1z_16{left:650px;bottom:535px;letter-spacing:-0.09px;word-spacing:-0.13px;}
#t20_16{left:650px;bottom:517px;letter-spacing:-0.06px;}
#t21_16{left:650px;bottom:498px;letter-spacing:-0.13px;}
#t22_16{left:673px;bottom:506px;}
#t23_16{left:650px;bottom:480px;letter-spacing:-0.06px;}
#t24_16{left:650px;bottom:462px;letter-spacing:-0.18px;word-spacing:-0.09px;}
#t25_16{left:816px;bottom:469px;letter-spacing:-0.12px;}
#t26_16{left:651px;bottom:422px;letter-spacing:-0.13px;}
#t27_16{left:674px;bottom:429px;}
#t28_16{left:651px;bottom:403px;letter-spacing:-0.06px;}
#t29_16{left:651px;bottom:385px;letter-spacing:-0.21px;word-spacing:-0.06px;}
#t2a_16{left:890px;bottom:393px;letter-spacing:-0.12px;}
#t2b_16{left:944px;bottom:289px;letter-spacing:-0.09px;}
#t2c_16{left:944px;bottom:271px;letter-spacing:-0.09px;}
#t2d_16{left:1010px;bottom:271px;letter-spacing:-0.25px;}
#t2e_16{left:665px;bottom:183px;}
#t2f_16{left:675px;bottom:177px;letter-spacing:-0.12px;word-spacing:-0.06px;}
#t2g_16{left:932px;bottom:177px;}
#t2h_16{left:665px;bottom:169px;}
#t2i_16{left:675px;bottom:164px;letter-spacing:-0.13px;word-spacing:-0.02px;}
#t2j_16{left:1134px;bottom:164px;}
#t2k_16{left:665px;bottom:155px;}
#t2l_16{left:675px;bottom:150px;letter-spacing:-0.11px;}
#t2m_16{left:673px;bottom:138px;letter-spacing:-0.13px;word-spacing:0.02px;}
#t2n_16{left:673px;bottom:125px;letter-spacing:-0.13px;word-spacing:0.02px;}
#t2o_16{left:1084px;bottom:125px;letter-spacing:-0.11px;}
#t2p_16{left:484px;bottom:287px;letter-spacing:-0.1px;}
#t2q_16{left:484px;bottom:267px;letter-spacing:-0.09px;}
#t2r_16{left:182px;bottom:350px;letter-spacing:-0.1px;}
#t2s_16{left:285px;bottom:358px;}
#t2t_16{left:944px;bottom:363px;letter-spacing:-0.09px;}
#t2u_16{left:944px;bottom:345px;letter-spacing:-0.09px;}
#t2v_16{left:1010px;bottom:345px;letter-spacing:-0.25px;}
#t2w_16{left:482px;bottom:360px;letter-spacing:-0.1px;}
#t2x_16{left:482px;bottom:340px;letter-spacing:-0.09px;}
#t2y_16{left:353px;bottom:643px;letter-spacing:-0.09px;}
#t2z_16{left:353px;bottom:625px;letter-spacing:-0.09px;}
#t30_16{left:508px;bottom:633px;}
#t31_16{left:663px;bottom:633px;letter-spacing:-0.11px;}
#t32_16{left:763px;bottom:641px;}
#t33_16{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_16{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_16{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_16{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_16{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_16{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_16{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_16{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_16{font-size:14px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_16{font-size:14px;font-family:ArialMT_5tg;color:#000;}
.s9_16{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sa_16{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_16{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_16{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts16" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg16Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg16" style="-webkit-user-select: none;"><object width="1210" height="935" data="16/16.svg" type="image/svg+xml" id="pdf16" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_16" class="t s0_16">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_16" class="t s1_16">® </span>
<span id="t3_16" class="t s0_16">(NCCN </span>
<span id="t4_16" class="t s1_16">® </span>
<span id="t5_16" class="t s0_16">), All rights reserved. NCCN Guidelines </span>
<span id="t6_16" class="t s1_16">® </span>
<span id="t7_16" class="t s0_16">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_16" class="t s2_16">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_16" class="t s2_16">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_16" class="t s3_16">NCCN Guidelines Version 4.2024 </span>
<span id="tb_16" class="t s3_16">Cancer of the Oropharynx (p16-negative) </span>
<span id="tc_16" class="t s4_16">NCCN Guidelines Index </span>
<span id="td_16" class="t s4_16">Table of Contents </span>
<span id="te_16" class="t s4_16">Discussion </span>
<span id="tf_16" class="t s5_16">ORPH-2 </span>
<span id="tg_16" class="t s6_16">k </span>
<span id="th_16" class="t s7_16">Principles of Surgery (SURG-A)</span><span id="ti_16" class="t s8_16">. </span>
<span id="tj_16" class="t s6_16">l </span>
<span id="tk_16" class="t s8_16">Tumors in the base of tongue, posterior pharyngeal wall, and soft palate require consideration of </span>
<span id="tl_16" class="t s8_16">bilateral neck treatment as do tumors of the tonsil invading the tongue base. </span>
<span id="tm_16" class="t s6_16">m </span>
<span id="tn_16" class="t s8_16">For pN0–N1 and no poor pathologic risk features, single-modality treatment should be considered </span>
<span id="to_16" class="t s8_16">whenever possible. For T1–T2 primary tumors near midline and resected to adequate margins and </span>
<span id="tp_16" class="t s8_16">with no adverse pathologic features, a staged contralateral neck dissection can be performed in order </span>
<span id="tq_16" class="t s8_16">to avoid RT. Lateral tumors pN0–N1 resected with favorable pathologic features can be observed. </span>
<span id="tr_16" class="t s5_16">Base of Tongue/Tonsil/Posterior Pharyngeal Wall/Soft Palate </span>
<span id="ts_16" class="t s5_16">CLINICAL </span>
<span id="tt_16" class="t s5_16">STAGING </span>
<span id="tu_16" class="t s5_16">TREATMENT OF PRIMARY AND NECK </span><span id="tv_16" class="t s5_16">ADJUVANT TREATMENT </span>
<span id="tw_16" class="t s5_16">Recurrent </span>
<span id="tx_16" class="t s5_16">or </span>
<span id="ty_16" class="t s5_16">persistent </span>
<span id="tz_16" class="t s5_16">disease </span>
<span id="t10_16" class="t s9_16">(ADV-3) </span>
<span id="t11_16" class="t s9_16">Follow-up </span>
<span id="t12_16" class="t s9_16">(FOLL-A, 1 </span>
<span id="t13_16" class="t s9_16">of 2) </span>
<span id="t14_16" class="t s5_16">p16-negative </span>
<span id="t15_16" class="t s5_16">T1–2,N0–1 </span>
<span id="t16_16" class="t s5_16">or </span>
<span id="t17_16" class="t s5_16">Resection of </span>
<span id="t18_16" class="t s5_16">primary </span>
<span id="t19_16" class="t s5_16">and ipsilateral </span>
<span id="t1a_16" class="t s5_16">or bilateral neck </span>
<span id="t1b_16" class="t s5_16">dissection </span>
<span id="t1c_16" class="t sa_16">k,l,m </span>
<span id="t1d_16" class="t s5_16">For T1–2,N1 only: </span>
<span id="t1e_16" class="t s5_16">Concurrent systemic therapy/RT </span>
<span id="t1f_16" class="t sa_16">n,o </span>
<span id="t1g_16" class="t s5_16">(category 2B) </span>
<span id="t1h_16" class="t s5_16">or </span>
<span id="t1i_16" class="t s5_16">or </span>
<span id="t1j_16" class="t s5_16">Clinical trials </span>
<span id="t1k_16" class="t s5_16">pN0 and no adverse </span>
<span id="t1l_16" class="t s5_16">pathologic features </span>
<span id="t1m_16" class="t sa_16">p </span>
<span id="t1n_16" class="t s5_16">Adverse </span>
<span id="t1o_16" class="t s5_16">pathologic </span>
<span id="t1p_16" class="t s5_16">features </span>
<span id="t1q_16" class="t sa_16">p </span>
<span id="t1r_16" class="t s5_16">Extranodal </span>
<span id="t1s_16" class="t s5_16">extension ± </span>
<span id="t1t_16" class="t s5_16">positive margin </span>
<span id="t1u_16" class="t s5_16">Positive margin </span>
<span id="t1v_16" class="t s5_16">Other risk </span>
<span id="t1w_16" class="t s5_16">features </span>
<span id="t1x_16" class="t s5_16">Systemic therapy/RT </span>
<span id="t1y_16" class="t sa_16">n,o </span>
<span id="t1z_16" class="t s5_16">Re-resection, if feasible </span>
<span id="t20_16" class="t s5_16">or </span>
<span id="t21_16" class="t s5_16">RT </span>
<span id="t22_16" class="t sa_16">n </span>
<span id="t23_16" class="t s5_16">or </span>
<span id="t24_16" class="t s5_16">Systemic therapy/RT </span>
<span id="t25_16" class="t sa_16">n,o </span>
<span id="t26_16" class="t s5_16">RT </span>
<span id="t27_16" class="t sa_16">n </span>
<span id="t28_16" class="t s5_16">or </span>
<span id="t29_16" class="t s5_16">Consider systemic therapy/RT </span>
<span id="t2a_16" class="t sa_16">n,o </span>
<span id="t2b_16" class="t s5_16">Recurrent or persistent </span>
<span id="t2c_16" class="t s5_16">disease </span><span id="t2d_16" class="t s9_16">(ADV-3) </span>
<span id="t2e_16" class="t s6_16">n </span>
<span id="t2f_16" class="t s7_16">Principles of Radiation Therapy (ORPH-A)</span><span id="t2g_16" class="t s8_16">. </span>
<span id="t2h_16" class="t s6_16">o </span>
<span id="t2i_16" class="t s7_16">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2j_16" class="t s8_16">. </span>
<span id="t2k_16" class="t s6_16">p </span>
<span id="t2l_16" class="t s8_16">Adverse pathologic features: extranodal extension, positive margins, close </span>
<span id="t2m_16" class="t s8_16">margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, nodal disease in levels IV </span>
<span id="t2n_16" class="t s8_16">or V, perineural invasion, vascular invasion, and lymphatic invasion </span><span id="t2o_16" class="t s7_16">(Discussion). </span>
<span id="t2p_16" class="t s9_16">Post Systemic Therapy/RT or RT </span>
<span id="t2q_16" class="t s9_16">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2r_16" class="t sb_16" data-mappings='[[2,"fi"]]'>Deﬁnitive RT </span>
<span id="t2s_16" class="t sa_16">n </span>
<span id="t2t_16" class="t s5_16">Recurrent or persistent </span>
<span id="t2u_16" class="t s5_16">disease </span><span id="t2v_16" class="t s9_16">(ADV-3) </span>
<span id="t2w_16" class="t s9_16">Post Systemic Therapy/RT or RT </span>
<span id="t2x_16" class="t s9_16">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2y_16" class="t s5_16">pN1 without other adverse </span>
<span id="t2z_16" class="t s5_16">pathologic features </span>
<span id="t30_16" class="t sa_16">p </span>
<span id="t31_16" class="t s5_16">Consider RT </span>
<span id="t32_16" class="t sa_16">n </span>
<span id="t33_16" class="t sc_16">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
